Professional Documents
Culture Documents
Structural Growth
Back on the Menu
Our monthly view on Australian equities.
07 September 2022
Issued by Wilsons Advisory and Stockbroking Limited (Wilsons) ABN 68 010 529 665 - Australian Financial Services Licence No 238375, a participant of ASX Group and
should be read in conjunction with the disclosures and disclaimer in this report.
August Recap
The Australian equity market
Figure 1: Energy and Materials led the charge in August
edged higher in August, posting a solid
0.6% gain for the month. Higher than A-REITs
the MSCI World (US$), which was
Consumer Staples
down 2.6%.
Utilities
Reporting season demonstrated the
Financials
resilience of corporate earnings as
companies reported generally positive IT
results that, on average, exceeded
expectations for FY22. Consumer Discretionary
Healthcare
Read Reporting Season Wrap-up
ASX 300
The market’s optimism was dampened
towards the end of the month by Industrials
Federal Reserve Chair Jerome Powell’s
Communication Services
comments at the Jackson Hole Economic
Symposium, which reaffirmed the Materials
central bank’s commitment to bringing
inflation into line with its 2% target while Energy
acknowledging this will bring ‘some pain’
-6% -4% -2% 0% 2% 4% 6% 8%
to households and businesses.
Source: Refinitiv, Wilsons. 1 month price change %
Interest rate pressures intensified
throughout the month as the US 10-year
yield reversed course from its recent Figure 2: EV minerals and coal account for the top 4 best performing ASX 100
trend, grinding 50 BPS higher to 3.15% at stocks in August
month end.
OZL
The energy and materials sectors
performed the strongest as they PLS
were buoyed by strong results from
companies exposed to coal, LNG, and WHC
EV minerals (i.e. copper, lithium, nickel
and rare earths). AKE
Defensive sectors fared the worst during
A2M
the month. The interest rate-sensitive
A-REIT sector was the weakest performer NXT
as it felt the valuation impact of rising
yields. Consumer staples and utilities ASX
were weighed down by disappointing
results and forward earnings downgrades RWC
during the month.
BEN
From an individual stock perspective, the
best performing ASX 100 stocks were OZ DMP
Minerals (OZL) (Focus List 2%) (+36.2%),
which rejected a takeover bid from BHP
-20% -10% 0% 10% 20% 30% 40%
Group (BHP) during the month, as well
as Pilbara Minerals (PLS) (+31.8%) and Source: Refinitiv, Wilsons. % price change in August
Whitehaven Coal (WHC) (+28.2%). The
worst performers were Dominos (DMP)
(-12.3%), Bendigo Bank (BEN) (-12.2%)
and Reliance Worldwide (RWC) (-11.4%).
2
ISG Outlook
This month includes a number of
short-term tests, and these tests could Figure 3: Bond yields crept up in August; we think they have likely peaked
set the tone for the rest of the year.
4.5
US inflation a key data point
4.0
this month
The Australian equity market is 3.5
sometimes at the mercy of what
happens in the US. The US 10-year bond 3.0
yield is generally seen as a global proxy
for the risk-free rate and is therefore 2.5
significant to global markets outside the
US, like Australia. 2.0
Oct-20
Jan-22
Oct-17
Oct-18
Jan-20
Jan-21
Jul-21
Jul-22
Jan-18
Jan-19
Jul-19
Jul-20
Jul-17
Jul-18
Apr-22
Apr-20
Apr-21
Apr-18
Apr-19
3
Figure 5: Focus List positioning
Cyclical
Growth
The Focus List has a structural bias towards quality growth. We still
hold these stocks as we believe they have a strong growth trajectory
over the medium term, but higher bond yields have heightened
ALL, GMG,
valuation pressure over the past 6 months. In our opinion, the
Structural Growth 11.5% 13.5% 7.7% SEK, PNI,
NXT
growth stocks in the Focus List have been oversold over the past
few months. US and Australian bond yields look to have peaked,
while our preferred growth exposures have tangible earnings
growth prospects.
4
We currently have a preference for quality defensives. In a mid-
late cycle, we prefer companies we believe will be resilient to the
CSL, IAG, downside risks that are more prevalent in this part of the cycle.
TLS, HCW,
Quality Defensive 25.0% 26.0% 28.7% Additionally, given the level of uncertainty and volatility that is
TLC, CWY,
RMD persistent in markets at the moment, we believe holding names that
are less sensitive to the economy and rising rates to be a prudent
decision. Our picks are healthcare, lotteries, insurance and telcos.
Hidden Value
-
2022 2023 2024 2025 2026
Total hyperscale data centre capacity leased globally
Source: Digital Realty Trust Q2 2022 Presentation, McKinsey & Company Report, IMR, Wilsons.
5
2. Steady and predictable growth
NXT has proven over time that it can
grow EBITDA. Even with equity raises, Figure 7: NXT has continued to grow EBITDA over time
the stock has continued to grow its
1000 60%
EBITDA per share. We think NXT has a
first-mover advantage in the space and
can continue to grow EBITDA over the 800
55%
medium-term.
Costs (including energy costs) should be Digital Realty Trust* 19.2x 17.7x 16.3x 9%
passed on to customers via pass-through
Equinix* 20.0x 18.2x 16.4x 10%
mechanisms in contracts, so margin
compression is a low risk for NXT. Macquarie Telecom 15.6x 13.5x 12.7x 11%
For new sites, cost growth will initially Goodman Group 19.3x 17.7x 15.9x 10%
outstrip revenue growth, but once Group Average 19.4x 17.8x 17.3x 6%
operational, the first data centres (S1 and
*Dec year end's use a pro rated average to make them comparable.
M1) reached breakeven by 7-11 months. Source: Refinitiv, Wilsons
We continue to expect group-level
margin expansion as NXT scales further. Equinix’s (19% vs 9%), which reflects both Wilsons coverage
the higher growth trajectory and the
5. Valuation multiples high but looks smaller scale of NXT vs Equinix.
Our analysts discussed NXT’s most
reasonable versus peers recent results.
In the US, data centres are considered
Our analysts have NXT at a price target Read Rock Steady, No Doubt. FY23e
to be infrastructure stocks. If we also
of $11.55, which implies an expected Guidance In-line with Expectations.
look at NXT against other ASX-listed
return of ~17% at the close on Monday.
infrastructure peers (which we think are
NXT is trading at a slight EV/EBITDA also appropriate peers), the stock has
premium to its closest peer Equinix, but a slight premium to these names but
NXT’s 3-year EBITDA compound annual significantly higher growth. Therefore,
growth rate (CAGR) is more than double we believe NXT looks well-priced and
potentially oversold.
6
Other Changes to the Focus List
Adding to ResMed (RMD) +1% Removing Judo Bank (JDO) -1% Trimming BHP Group (BHP) -2%
After adding RMD to the Focus List When we added JDO, we believed that Since the beginning of the year, the
at the beginning of last month, we there was a good runway for growth to Focus List has been underweight iron
decided to increase our weighting after build its loan book in an environment of ore miners. We continue to believe the
a good FY22 result and a weak price robust economic growth and a relatively fundamentals for iron ore (and
performance in August. cautious RBA. the miners that produce it) are skewed
to the downside over the medium-term.
For the Focus List, RMD: Over the past 12 months, the RBA has Therefore, we decided to decrease
been more hawkish than we expected, our weighting to BHP to go
• Increases quality to the portfolio and economic growth is likely to more underweight.
(dominant market position after the slow quicker than expected. In this
Phillips recall). environment, we believe it will be hard We recently discussed our views on
• Lowers the beta (relatively to build a loan book at the pace JDO iron ore.
defensive earnings). is guiding towards, and bad debts may
become an issue (more of an issue than Read Iron Ore: Risk Remains to
• Increases earnings growth
the big 4 banks). the Downside
(higher expected growth but higher
earnings multiple).
We have removed JDO as it is also
Our analysts recently upgraded their leveraged to the domestic economy
view on RMD to overweight. and we have a preference to quality over
cyclicals over the next 12 months.
Read Upgrade O/W: An S9 in an
AS10’s clothing
7
Focus on the Reporting Season
Overall the Focus List had more beats What we liked What we disliked
than misses in reporting season. We
assess that 61% of Focus List results Qantas (QAN) (Focus List 4%) Santos (STO) (Focus List 4%)
(by portfolio weight %) were inline with
QAN’s full year result was well received The market was disappointed on the
consensus forecasts (15 companies),
by the market, which was positioned capital management front, as STO
28% outperformed expectations
somewhat cautiously with respect to announced an interim dividend of
(9 companies), and 12% disappointed the
QAN heading into the update. US$7.6cps. This reflected a payout ratio
market (4 companies).
of ~35% of free cash flows and undershot
Most notably, in our view, QAN’s recovery consensus expectations of US$10.7cps.
Figure 9: The Focus List had a low post-COVID remains on track as we had That said, management did announce an
percentage of misses by weighting expected. In FY23, management expects increase in its on-market buyback from
domestic capacity to hit 101% of FY19 US$250m to US$350m.
levels, while international capacity is
expected to be 75% of FY19 levels, albeit We still like Santos as it is poised to
Miss with higher fuel costs. benefit from buoyant energy prices.
8
Figure 10: Focus List results summary
2d price
EPS 12mth
change
Company Name Ticker Sector surprise vs fwd EPS Comment
on day of
consensus revisions**
result
Beats
Healthco FFO for FY22 was 5.1 cpu, which was ~3% above the most
Healthcare and HCW Real Estate 8.2% 2.7% -10.1% recent guidance of 5 cps and was +18% above initial PDS
Wellness REIT forecasts. FY22 DPS was 7.5 cps in line with PDS guidance.
Pinnacle Investment Underlying FY22 NPAT was $78.2m, +16.6% YoY and +1.8%
PNI Financials 8.4% 0.3% 1.5%
Management vs consensus (+0.9% vs. WILSe).
Inline
9
1H EBITDA miss due to disruptions ($358m vs cons $404m),
OZ Minerals OZL Materials -4.4% -4.4% -8.0%
but FY production/cost guidance reaffirmed.
Information
Xero XRO NA NA 5.0% Nothing material. FY guidance reaffirmed.
Technology
Misses
James Hardie JHX Materials -1.1% -0.7% -2.0% Q1 EBIT US$154m vs cons US$162m, guidance downgrade.
Telix Telix reported a 1H22 loss of $70M which was higher than
TLX Healthcare -18.9% NA NA
Pharmaceuticals the market modelled.
*beats/meets/misses a reflection of our best assessment considering on all the relavent variables.
**over last 30 days as of 5/9/2022
***CWY 2d change refers to difference between close on 19 August to 23 August to account for trading halt.
Source: Refinitiv, Wilsons.
Resources
Banks
Quality Defensive
Structural Growth
-2.5% -2.0% -1.5% -1.0% -0.5% 0.0% 0.5% 1.0% 1.5% 2.0% 2.5%
Source: Refinitiv, Wilsons. Change in weighting since last month (percentage points)
10
Figure 12: Fundamental table for the Focus List
Net Consensus
Dividend Recommendation
Forecast Multiples EPS CAGR % ROE Debt/
Market Cap Yield %
Company Name Ticker Weighting Beta Share Price EBITDA Mean
(US$b)
12mth fwd 12mth fwd (5 = Strong Sell,
(FY1-FY3) 12mth fwd (FY1) (FY1) 1 = Strong Buy)
PE EV/EBITDA
Communication Services
News Corp NWS 2.5% 1.15 25.36 14.6 18.4 6.8 -1% 1% 6% 0.5 2.3
Seek SEK 2.5% 0.77 20.59 7.3 27.7 15.1 8% 2% 14% 1.8 2.4
Telstra TLS 3.0% 0.61 3.94 45.4 23.0 7.6 12% 4% 12% 1.4 2.2
Consumer Discretionary
Aristocrat Leisure ALL 4.0% 1.26 34.58 22.9 18.5 11.2 15% 2% 23% -0.3 2.1
Lottery Corp TLC 3.0% 1.00 4.48 9.9 27.7 16.4 4% 3% 151% 2.9 2.4
Tabcorp TAH 1.0% 1.17 0.95 2.1 23.7 5.5 36% 3% 3% 0.6 2.6
Energy
Santos STO 4.0% 1.93 7.73 25.9 7.0 3.8 9% 5% 19% 0.5 1.8
Woodside Energy WDS 3.0% 1.24 33.65 63.7 7.2 3.9 15% 9% 24% 0.2 2.3
Financials
IAG IAG 3.0% 0.32 4.68 11.5 14.3 9.5 67% 6% 14% NA 2.4
Macquarie Group MQG 6.0% 1.47 177.20 69.0 16.3 26.1 -2% 4% 14% NA 2.4
Pinnacle Investment
PNI 1.0% 2.19 9.79 1.9 22.9 21.1 13% 3.7% 20% 0.6 2.6
Management
Healthcare
CSL CSL 8.5% 0.45 295.99 142.6 34.9 20.7 16% 1% 17% 2.3 2.1
Resmed RMD 3.5% 0.27 32.11 46.5 32.7 22.6 10% 1% 26% -0.3 2.4
Telix Pharmaceuticals TLX 2.0% 2.31 5.85 1.8 0% -153% 1.2 1.9
Industrials
Cleanaway Waste
CWY 3.0% 1.28 2.80 6.2 33.0 11.3 17% 2% 6% 1.8 2.5
Management
Qantas Airways QAN 4.0% 1.38 5.28 9.9 10.5 3.9 2% 1.1 2.1
Information Technology
NEXTDC NXT 2.0% 0.23 10.23 4.7 305.6 25.3 69% 0% 1% 4.7 2.0
Xero XRO 2.0% 1.33 83.37 12.5 160.8 39.4 137% 0% 5% -0.5 2.4
Materials
Allkem AKE 3.0% 1.86 13.20 8.4 9.3 5.0 31% 0% 19% -0.7 2.2
BHP Group BHP 6.0% 0.86 36.74 186.1 8.1 4.0 -16% 9% 35% 0.1 2.5
James Hardie Industries JHX 3.0% 1.55 33.24 14.8 13.4 9.0 9% 4% 46% 0.6 1.9
Northern Star Resources NST 2.5% 0.91 7.38 8.6 17.5 4.8 34% 3% 5% -0.2 1.7
OZ Minerals OZL 2.0% 1.29 25.33 8.5 23.9 10.1 -9% 1% 7% 0.8 2.5
Real Estate
Goodman Group GMG 4.0% 1.01 19.21 36.0 20.1 18.9 12% 2% 11% 0.8 2.0
Healthco REIT HCW 2.0% 0.80 1.78 0.6 24.8 20.9 20% 5% 3% 8.2 2.3
11
Disclaimer and Disclosures
Recommendation structure and other definitions
Definitions at www.wilsonsadvisory.com.au/disclosures.
Disclaimer
All figures and data presented in this research are accurate at the date of the report, unless otherwise stated.
Wilsons Australian Equity Focus List (Focus List) is a weighted list of the Investment Strategy Group’s (ISG) preferred companies. The
Focus List aims to hold around 25-30 companies, largely taken from the S&P/ASX 300. Stocks may be substituted at any time at the
discretion of the ISG. Performance numbers around the Focus List are unaudited, and should be used only as a guide to indicate
returns if investors were to follow the Focus List. For further information please contact your Wilsons Advisor.
This document has been prepared by Wilsons Advisory and Stockbroking Limited (AFSL 238375, ABN 68 010 529 665) (“Wilsons”) and
its authors without consultation with any third parties, nor is Wilsons authorised to provide any information or make any representation
or warranty on behalf of such parties. Any opinions contained in this document are subject to change and do not necessarily reflect
the views of Wilsons. This document has not been prepared or reviewed by Wilsons' Research Department and does not constitute
investment research. Wilsons makes no representation or warranty, express or implied, as to the accuracy or completeness of the
information and opinions contained therein, and no reliance should be placed on this document in making any investment decision
Any projections contained in this communication are estimates only. Such projections are subject to market influences and contingent
upon matters outside the control of Wilsons and therefore may not be realised in the future. Past performance is not an indication of
future performance.
In preparing the information in this document Wilsons did not take into consideration the investment objectives, financial situation
or particular needs of any particular investor. Any advice contained in this document is general advice only. Before making any
investment decision, you should consider your own investment needs and objectives and should seek financial advice. You should
consider the Product Disclosure Statement or prospectus in deciding whether to acquire a product. The Product Disclosure Statement
or Prospectus is available through your financial adviser.
Wilsons Corporate Finance Limited ACN 057 547 323, AFSL 238 383 may have participated in some capacity with regard to capital
raisings for some of the companies mentioned in this article. To manage any conflicts of interest with Wilsons Research, full disclosure
on any relevant corporate transaction may be found on our website.
Wilsons contact
david.cassidy@wilsonsadvisory.com.au | +61 2 8247 3149
www.wilsonsadvisory.com.au
12